No dips to buy?, developing the vaccine and a big ransomware target
‘Buying the dip’ is something we’re often told from Wall Street strategists. But what if there aren’t any dips to buy? We’ll discuss. Plus, we’ll speak with one of the key researchers behind the Pfizer vaccine about the breakthrough technology and why she’s not concerned about variants. And, as Apple announced its new product lineup, a key supplier was suffering a multibillion dollar ransomware attack aimed at stealing Apple’s blueprints. We’ll explain.
April 21, 202144m 36s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
‘Buying the dip’ is something we’re often told from Wall Street strategists. But what if there aren’t any dips to buy? We’ll discuss. Plus, we’ll speak with one of the key researchers behind the Pfizer vaccine about the breakthrough technology and why she’s not concerned about variants. And, as Apple announced its new product lineup, a key supplier was suffering a multibillion dollar ransomware attack aimed at stealing Apple’s blueprints. We’ll explain. Hosted by Simplecast, an AdsWizz company. See https://pcm.adswizz.com
for information about our collection and use of personal data for
advertising.